Sato K - Search Results

1

Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).

Katakami N, Uchino J, Yokoyama T, Naito T, Kondo M, Yamada K, Kitajima H, Yoshimori K, Sato K, Saito H, Aoe K, Tsuji T, Takiguchi Y, Takayama K, Komura N, Takiguchi T, Eguchi K. Katakami N, et al. Among authors: sato k. Cancer. 2018 Feb 1;124(3):606-616. doi: 10.1002/cncr.31128. Epub 2017 Dec 4. Cancer. 2018. PMID: 29205286 Free PMC article. Clinical Trial.

2

[Clinical features of acute exacerbation of interstitial pneumonia associated with lung cancer after chemotherapy].

Sato K, Shimaoka Y, Hayashi Y, Suzuki N, Ebe Y. Sato K, et al. Gan To Kagaku Ryoho. 2009 Sep;36(9):1493-7. Gan To Kagaku Ryoho. 2009. PMID: 19755819 Japanese.

3

Endothelial progenitor cells are associated with response to chemotherapy in human non-small-cell lung cancer.

Morita R, Sato K, Nakano M, Miura H, Odaka H, Nobori K, Kosaka T, Sano M, Watanabe H, Shioya T, Ito H. Morita R, et al. Among authors: sato k. J Cancer Res Clin Oncol. 2011 Dec;137(12):1849-57. doi: 10.1007/s00432-011-1043-8. Epub 2011 Sep 17. J Cancer Res Clin Oncol. 2011. PMID: 21927909

4

Relationship Among Gefitinib Exposure, Polymorphisms of Its Metabolizing Enzymes and Transporters, and Side Effects in Japanese Patients With Non-Small-Cell Lung Cancer.

Kobayashi H, Sato K, Niioka T, Miura H, Ito H, Miura M. Kobayashi H, et al. Among authors: sato k. Clin Lung Cancer. 2015 Jul;16(4):274-81. doi: 10.1016/j.cllc.2014.12.004. Epub 2014 Dec 11. Clin Lung Cancer. 2015. PMID: 25554506 Clinical Trial.

5

Low plasma concentration of gefitinib in patients with EGFR exon 21 L858R point mutations shortens progression-free survival.

Okuda Y, Sato K, Sudo K, Hasegawa Y, Asano M, Miura H, Takeda M, Sano M, Watanabe H, Kobayashi H, Niioka T, Miura M, Ito H. Okuda Y, et al. Among authors: sato k. Cancer Chemother Pharmacol. 2017 May;79(5):1013-1020. doi: 10.1007/s00280-017-3285-x. Epub 2017 Apr 8. Cancer Chemother Pharmacol. 2017. PMID: 28391354

6

Effects of Histamine 2-receptor Antagonists and Proton Pump Inhibitors on the Pharmacokinetics of Gefitinib in Patients With Non-small-cell Lung Cancer.

Yokota H, Sato K, Okuda Y, Kobayashi H, Takeda M, Asano M, Ito H, Miura M. Yokota H, et al. Among authors: sato k. Clin Lung Cancer. 2017 Nov;18(6):e433-e439. doi: 10.1016/j.cllc.2017.05.010. Epub 2017 May 10. Clin Lung Cancer. 2017. PMID: 28579188

7

A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer.

Kondo R, Watanabe S, Shoji S, Ichikawa K, Abe T, Baba J, Tanaka J, Tsukada H, Terada M, Sato K, Maruyama Y, Makino M, Hirata A, Tanaka H, Koya T, Yoshizawa H, Kikuchi T. Kondo R, et al. Among authors: sato k. Oncology. 2018;94(4):223-232. doi: 10.1159/000486622. Epub 2018 Feb 14. Oncology. 2018. PMID: 29444512 Clinical Trial.

8

Efficacy of EGFR-TKIs with or without upfront brain radiotherapy for EGFR-mutant NSCLC patients with central nervous system metastases.

Saida Y, Watanabe S, Abe T, Shoji S, Nozaki K, Ichikawa K, Kondo R, Koyama K, Miura S, Tanaka H, Okajima M, Terada M, Ishida T, Tsukada H, Makino M, Iwashima A, Sato K, Matsumoto N, Yoshizawa H, Kikuchi T. Saida Y, et al. Among authors: sato k. Thorac Cancer. 2019 Nov;10(11):2106-2116. doi: 10.1111/1759-7714.13189. Epub 2019 Sep 10. Thorac Cancer. 2019. PMID: 31507098 Free PMC article.

9

Prognostic significance of the radiologic features of pneumonitis induced by anti-PD-1 therapy.

Watanabe S, Ota T, Hayashi M, Ishikawa H, Otsubo A, Shoji S, Nozaki K, Ichikawa K, Kondo R, Miyabayashi T, Miura S, Tanaka H, Abe T, Okajima M, Terada M, Ishida T, Iwashima A, Sato K, Yoshizawa H, Kikuchi T. Watanabe S, et al. Among authors: sato k. Cancer Med. 2020 May;9(9):3070-3077. doi: 10.1002/cam4.2974. Epub 2020 Mar 9. Cancer Med. 2020. PMID: 32150668 Free PMC article.

10

Effects of STAT3 polymorphisms and pharmacokinetics on the clinical outcomes of gefitinib treatment in patients with EGFR-mutation positive non-small cell lung cancer.

Yokota H, Sato K, Sakamoto S, Okuda Y, Asano M, Takeda M, Nakayama K, Miura M. Yokota H, et al. Among authors: sato k. J Clin Pharm Ther. 2020 Aug;45(4):652-659. doi: 10.1111/jcpt.13173. Epub 2020 May 13. J Clin Pharm Ther. 2020. PMID: 32402096

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,886 results

Search Page